Open access
Open access
Powered by Google Translator Translator

Nuclear Medicine

RCT | Increased detection of metastases via PET-CT alters treatment path in locally advanced breast cancer

16 Jun, 2023 | 14:02h | UTC

Impact of 18F-Labeled Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Versus Conventional Staging in Patients With Locally Advanced Breast Cancer – Journal of Clinical Oncology (link to abstract – $ for full-text)

 


A review of modern imaging landscape for prostate cancer: a comprehensive clinical guide

9 May, 2023 | 14:34h | UTC

A Review of Modern Imaging Landscape for Prostate Cancer: A Comprehensive Clinical Guide – Journal of Clinical Medicine

 


Metomidate PET-CT vs. adrenal vein sampling for diagnosing surgically curable primary aldosteronism: a prospective, within-patient trial

19 Jan, 2023 | 14:19h | UTC

[11C]metomidate PET-CT versus adrenal vein sampling for diagnosing surgically curable primary aldosteronism: a prospective, within-patient trial – Nature Medicine

News Release: Ten-minute scan enables detection and cure of the commonest cause of high blood pressure – Queen Mary University of London

 


Guideline | Use of [18F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors

19 Jan, 2023 | 14:13h | UTC

Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [18F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors version 1.0 – European Journal of Nuclear Medicine and Molecular Imaging

See also: Perspectives on joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards for [18F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors – Cancer Imaging

 


EANM practice guideline for quantitative SPECT-CT.

13 Dec, 2022 | 14:26h | UTC

EANM practice guideline for quantitative SPECT-CT – European Journal of Nuclear Medicine and Molecular Imaging

 


18F-sodium fluoride PET–CT vs. 99mTc bone scintigraphy with SPECT in patients with prostate cancer or breast cancer.

22 Nov, 2022 | 13:09h | UTC

Intra-individual comparison of 18F-sodium fluoride PET–CT and 99mTc bone scintigraphy with SPECT in patients with prostate cancer or breast cancer at high risk for skeletal metastases (MITNEC-A1): a multicentre, phase 3 trial – The Lancet Oncology (link to abstract – $ for full-text) 

Commentary: 18F-NaF PET-CT More Accurate Than 99mTc-MDP SPECT for Detecting Bone Metastasis – Cancer Therapy Advisor 

 


PSMA and FDG-PET as predictive and prognostic biomarkers in patients given radioisotope therapy for prostate cancer.

22 Nov, 2022 | 12:56h | UTC

PSMA and FDG-PET as predictive and prognostic biomarkers in patients given [177Lu]Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP): a biomarker analysis from a randomised, open-label, phase 2 trial – The Lancet Oncology (link to abstract – $ for full-text) 

Commentary: PSMA-PET SUVmean Linked With Favorable Response to 177Lu-PSMA-617 in mCRPC – Targeted Oncology 

 


Consensus Statements | Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in patients with prostate cancer and with respect to [177Lu] Lu-PSMA radioligand therapy.

6 Jul, 2022 | 11:39h | UTC

EAU-EANM Consensus Statements on the Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Patients with Prostate Cancer and with Respect to [177Lu]Lu-PSMA Radioligand Therapy – European Urology Oncology


RCT | CT vs. [18F]FDG-PET-CT for persistent or recurrent neutropenic fever in high-risk patients.

4 Jul, 2022 | 12:21h | UTC

[18F]FDG-PET-CT compared with CT for persistent or recurrent neutropenic fever in high-risk patients (PIPPIN): a multicentre, open-label, phase 3, randomised, controlled trial – The Lancet Haematology (link to abstract – $ for full-text)

 

Commentary on Twitter


M-A: Accuracy of Fluorodeoxyglucose Positron Emission Tomography/ Computerized Tomography for diagnosing periprosthetic joint infections.

21 Jun, 2022 | 10:38h | UTC

A Systematic Review and Meta-Analysis on the Accuracy of Fluorodeoxyglucose Positron Emission Tomography/ Computerized Tomography for Diagnosing Periprosthetic Joint Infections – Frontiers in Surgery

 


Position Paper | Individualized treatment of differentiated thyroid cancer: The value of surgery in combination with radioiodine imaging and therapy.

24 Mar, 2022 | 08:34h | UTC

Individualized treatment of differentiated thyroid cancer: The value of surgery in combination with radioiodine imaging and therapy – A German position paper from Surgery and Nuclear Medicine – Nuclear Medicine

Related: RCT: In patients with low-risk thyroid cancer, thyroidectomy without ablation radioiodine was noninferior to thyroidectomy with ablation radioiodine at 3 years.

 


Multicenter comparative accuracy trial: Dynamic contrast-enhanced CT vs. positron emission tomography CT to characterize solitary pulmonary nodules.

16 Mar, 2022 | 08:51h | UTC

Abstract: Dynamic contrast-enhanced CT compared with positron emission tomography CT to characterise solitary pulmonary nodules: the SPUtNIk diagnostic accuracy study and economic modelling – Health Technology Assessment

Download: Full Report

 


Review | Molecular imaging in oncology: Current impact and future directions.

11 Feb, 2022 | 08:12h | UTC

Molecular imaging in oncology: Current impact and future directions – CA: A Cancer Journal for Clinicians

 


Prolonged follow-up of RCT: Emission Tomography–driven strategy in advanced Hodgkin Lymphoma.

19 Jan, 2022 | 08:16h | UTC

Positron Emission Tomography–Driven Strategy in Advanced Hodgkin Lymphoma: Prolonged Follow-Up of the AHL2011 Phase III Lymphoma Study Association Study – Journal of Clinical Oncology (link to abstract – $ for full-text)

 


Consensus Document: Non-invasive imaging in coronary syndromes.

10 Nov, 2021 | 07:11h | UTC

Non-invasive Imaging in Coronary Syndromes — Recommendations of the European Association of Cardiovascular Imaging and the American Society of Echocardiography, in Collaboration with the American Society of Nuclear Cardiology, Society of Cardiovascular Computed Tomography and Society for Cardiovascular Magnetic Resonance – European Heart Journal: Cardiovascular Imaging

 


Consensus Document: Multimodality imaging in patients with heart failure and preserved ejection fraction.

10 Nov, 2021 | 07:09h | UTC

Multimodality imaging in patients with heart failure and preserved ejection fraction: an expert consensus document of the European Association of Cardiovascular Imaging – European Heart Journal: Cardiovascular Imaging

 


M-A: Direct comparison of preoperative imaging modalities for localization of primary hyperparathyroidism – “choline PET-CT would be the best preoperative imaging modality for localization of primary hyperparathyroidism”.

6 Jun, 2021 | 23:40h | UTC

Direct Comparison of Preoperative Imaging Modalities for Localization of Primary Hyperparathyroidism: A Systematic Review and Network Meta-analysis –

JAMA Otolaryngology – Head & Neck Surgery (free for a limited period)

Invited commentary: Localization Studies for Parathyroid Surgery (free for a limited period)

 


RCT: Inclusion of 18F-fluciclovine-PET/CT imaging to guide postprostatectomy salvage radiotherapy in patients with prostate cancer may improve survival free from biochemical recurrence or persistence.

10 May, 2021 | 00:46h | UTC

18F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trial – The Lancet (link to abstract – $ for full-text)

 


PET imaging reveals which breast cancer patients won’t respond to hormone therapy

10 Feb, 2021 | 01:09h | UTC

PET Imaging Reveals Which Breast Cancer Patients Won’t Respond to Hormone Therapy – Diagnostic Imaging

Original study: Association of PET-based estradiol-challenge test for breast cancer progesterone receptors with response to endocrine therapy – Nature Communications

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.